Seeing Is Believing
Currently out of the existing stock ratings of Julian Harrison, 31 are a BUY (88.57%), 4 are a HOLD (11.43%).
Analyst Julian Harrison works at BTIG with a stock forecast success ratio of 47.73% fulfilled within 266.36 days on average.
Julian Harrison’s has documented 65 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CBAY, Cymabay Therapeu at 13-Feb-2024.
Analyst best performing recommendations are on AVTE (AEROVATE THERAPEUTICS).
The best stock recommendation documented was for AVTE (AEROVATE THERAPEUTICS) at 12/6/2022. The price target of $27 was fulfilled within 6 days with a profit of $8.97 (49.75%) receiving and performance score of 82.92.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
38
$11.39 (42.80%)
38
1 months 13 days ago
5/17 (29.41%)
$7.88 (26.16%)
226
Buy
42
$15.39 (57.84%)
37
1 months 13 days ago
3/6 (50%)
$11.88 (39.44%)
211
Buy
37
$10.39 (39.05%)
34
1 months 27 days ago
0/2 (0%)
$6.57 (21.59%)
Buy
35
$8.39 (31.53%)
35
9 months 21 days ago
0/10 (0%)
$12.69 (56.88%)
Buy
41
$14.39 (54.08%)
45
9 months 21 days ago
0/3 (0%)
$18.69 (83.77%)
Which stock is Julian Harrison is most bullish on?
Which stock is Julian Harrison is most reserved on?
What Year was the first public recommendation made by Julian Harrison?